Company / R&D per Share
Cooper Companies (The) R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.86
FY2025
5-year range
$0.78 / $2.79
FY2021-FY2025
Trend
+10.2%
vs FY2024
Sector context
#72 of 103
Health Care
What the data says
At $0.86, Cooper Companies (The)'s r&d per share ranks #72 of 103 in the Health Care sector. Declined from $2.79 to $0.86 over the past 2 years.
Based on SEC 10-K filings.
0.86 in FY2025 with a 5-year CAGR of -14.4%.
Declined from $2.79 to $0.86 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -27.2%
- 5-Year CAGR
- -14.4%
- 10-Year CAGR
- -
Sector benchmark
#72 of 103 in Health CareTop 70% of 103This company $0.86 Sector average $2.13
▼
-59.5% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 10.2% year-over-year.
- Ranks #72 out of 103 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2023.
- Lowest r&d per share in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.86 | +10.2% |
| FY2024 | $0.78 | -71.9% |
| FY2023 | $2.79 | +24.6% |
| FY2022 | $2.24 | +18.5% |
| FY2021 | $1.89 | +0.6% |
| FY2020 | $1.88 | +7.4% |
| FY2019 | $1.75 | +1.0% |
| FY2018 | $1.73 | +23.0% |
| FY2017 | $1.41 | +5.3% |
| FY2016 | $1.34 | -4.6% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026